Fundz

Mimi Vax reported raising $5.78 Million in an initial SEC Form D filing, from an offering of $5.78 Million

PRIVATEJul 12, 2024Late filing, first sale Oct 6, 2023

Amount Raised

$5.78 Million

$5.78 Million sold, per SEC Form D (first sale Oct 6, 2023)

Round Type

Venture

BuffaloBiotechnology

Who else raised in Biotechnology around the same time

Companies in the same sectors as MimiVax that raised within 45 days of this round, from Fundz verified event records.

  • Medicovestor raised an undisclosed amount (Seed) on November 20, 2023.
  • Alto Neuroscience raised $45M on November 20, 2023.
  • RespiQ raised $4.4M (Seed) on November 20, 2023.
  • Viva Biotech raised $210M (Funding Round) on November 20, 2023.
  • Solar Foods raised $8.7M (Series B) on November 20, 2023.
  • RCE Technologies raised $50K on November 20, 2023.

Who to call at MimiVax, and when

A new round usually means MimiVax is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day MimiVax raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at MimiVax, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at MimiVax. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

MimiVax

Location

Buffalo, New York, United States

About

MimiVax, Inc. is a Delaware-incorporated, clinical-stage biotechnology company focused on immunotherapy research and clinical translation of new agents for cancer treatment. The Company was formed to develop and commercialize its lead candidate SurVaxM.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment MimiVax raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts4 people are listed at MimiVax. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for MimiVax's next move

See what Strategic adds

MimiVax raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.